July 29, 2015
The accessible information standard tells organisations how they should ensure that disabled patients / service users and, where appropriate, carers and parents, receive information in formats that they can understand, and that they receive appropriate support to help them to communicate.
July 27, 2015
TACTT3 is a clinical study evaluating a novel treatment for acute tinnitus (onset within 6 months), an NMDA receptor antagonist administered via intratympanic injection. It is expected to complete recruitment by the end of the year.
As an audiologist or ENT-professional you may be interested in this research study.
The study website - http://www.tinnitus-study.info/uk-home - is the portal which lists the sites involved and through which patients can contact the nearest site.